Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial

Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial

Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the novel coronavirus (SARS-CoV-2). The phase 1 coronavirus clinical trial is being carried out under its own Investigational New Drug (IND) application by the National Institutes of Health (NIH). mRNA-1273 is […]